NCT05934019

Brief Summary

The goal of this randomized controlled clinical trial is to investigate the efficacy of the internet-delivered intervention EMPATIA on general psychopathology of adolescents with subclinical symptoms compared to a Care As Usual (CAU) control group. The primary objective is to:

  • investigate the efficacy of the internet-delivered intervention on general psychopathology of adolescents with subclinical symptoms compared to CAU.
  • secondary objectives include: clinician-rated interviews and self-report questionnaires on the level of social and role functioning, time until onset of a mental disorder and service use. Furthermore, changes in subclinical symptoms, transdiagnostic mechanisms and therapeutic as well as safety measures are assessed by online self-reports Participants will use the internet-delivered intervention EMPATIA during eight weeks. Researchers will compare intervention group to a Care As Usual (CAU) group to investigate the efficacy of the internet-delivered intervention EMPATIA on general psychopathology.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
158

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 26, 2023

Completed
14 days until next milestone

Study Start

First participant enrolled

June 9, 2023

Completed
27 days until next milestone

First Posted

Study publicly available on registry

July 6, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 18, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

March 2, 2026

Status Verified

February 1, 2026

Enrollment Period

1.8 years

First QC Date

May 26, 2023

Last Update Submit

February 26, 2026

Conditions

Outcome Measures

Primary Outcomes (5)

  • Level of self-reported general psychopathology

    Assessed by the "Strength and Difficulties Questionnaire, self-report" (SDQ-s; Becker et al., 2018). 25 Items with higher scores indicating higher level of self-reported general psychopathology.

    Baseline

  • Level of self-reported general psychopathology

    Assessed by the "Strength and Difficulties Questionnaire, self-report" (SDQ-s; Becker et al., 2018). 25 Items with higher scores indicating higher level of self-reported general psychopathology.

    Month 2

  • Level of self-reported general psychopathology

    Assessed by the "Strength and Difficulties Questionnaire, self-report" (SDQ-s; Becker et al., 2018). 25 Items with higher scores indicating higher level of self-reported general psychopathology.

    Month 6

  • Level of self-reported general psychopathology

    Assessed by the "Strength and Difficulties Questionnaire, self-report" (SDQ-s; Becker et al., 2018). 25 Items with higher scores indicating higher level of self-reported general psychopathology.

    Month 9

  • Level of self-reported general psychopathology

    Assessed by the "Strength and Difficulties Questionnaire, self-report" (SDQ-s; Becker et al., 2018). 25 Items with higher scores indicating higher level of self-reported general psychopathology.

    Month 12

Secondary Outcomes (32)

  • Level of social functioning

    Baseline and month 12

  • Level of role functioning

    Baseline and month 12

  • Time until onset of a mental disorder

    Baseline and month 12

  • Service Use

    Month 12

  • Depression

    Baseline, Month 2, 6, 9 and 12

  • +27 more secondary outcomes

Study Arms (2)

EMPATIA

EXPERIMENTAL

Participants in this group will access the online prevention program EMPATIA as a self-help online program during eight weeks.

Device: EMPATIA 1

Care As Usual

NO INTERVENTION

Participants in this group will gain access to the online prevention program EMPATIA after 12 months. All other kinds of interventions during participation are allowed and will be recorded using the Client Sociodemographic and Service Receipt Inventory

Interventions

EMPATIA 1DEVICE

The internet-program EMPATIA is hosted on a secure website https://selfhelp.psy.unibe.ch run by the Faculty of Human Sciences and is accessible from any regular internet browser. The software is not CE-marked as it has been developed for research purposes only. EMPATIA consists of 8 sessions and 1 booster session 3 weeks after the last session. It targets transdiagnostic mechanisms that have been identified in several mental disorders in adolescents: behavioral avoidance, repetitive negative thinking including intolerance of uncertainty, emotion, self-critical perfectionism and rejection sensitivity. The contents of EMPATIA are evidence-based and well-established cognitive-behavioral interventions dedicated to the respective transdiagnostic mechanism. The self-help program consists of psychoeducation, cognitive restructuring, relaxation and acceptance-based interventions, exposure and behavioral experiments and behavioral activation as treatment components.

EMPATIA

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Informed Consent signed by the subject (if the participant is ≥ 14 years) or signed by the legal guardians (if the participant is 12 or 13 years old).
  • Subjects are between 12 and 18 years old.
  • Subjects experience at least mild self-reported symptoms by scoring above the cut-off in at least one of the respective screening-instruments as assessed at the 12-month follow-up of the EMERGE- study.
  • Subjects have access to the internet and a smart phone, tablet or personal computer.
  • Subjects have sufficient knowledge of German.

You may not qualify if:

  • Current or lifetime diagnosis according to the "Diagnostic Interview for Mental Disorders for Children and Adolescents" (Kinder-DIPS, Margraf et al., 2017; Schneider et al., 2017) at baseline.
  • Score of '3' on the suicide item of the PHQ-A (Johnson et al., 2002) or active suicidal plans in the diagnostic telephone interview (Kinder- DIPS, Margraf et al., 2017; Schneider et al., 2017) at baseline.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Bern, Division of Clinical Child and Adolescent Psychology

Bern, 3012, Switzerland

Location

Related Publications (1)

  • Hirsig A, Hafeli XA, Schmidt SJ. Efficacy of a transdiagnostic Internet prevention approach in adolescents (EMPATIA study): study protocol of a randomized controlled trial. Trials. 2024 Aug 8;25(1):530. doi: 10.1186/s13063-024-08241-3.

Related Links

Study Officials

  • Stefanie J Schmidt, Prof. Dr.

    University of Bern, Devision of Clinical Child and Adolescent Psychology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Study participants cannot be blinded regarding the intervention condition as they realize whether they are in the condition using an online-program or not. Members of the study team guiding the participants as e-coaches during the online-program cannot be blinded as it is obvious for them that this is the condition receiving the online-program. Members of the study team who are conducting the diagnostic interviews do not have any other contact with the participants and will thus be blinded regarding the participants' assignment to the group conditions (EMPATIA vs. CAU).
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The present study is a monocentric, two-arm, single-blinded, randomized controlled trial with CAU as control condition.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 26, 2023

First Posted

July 6, 2023

Study Start

June 9, 2023

Primary Completion

March 18, 2025

Study Completion

September 1, 2025

Last Updated

March 2, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations